SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 07/16/15 -- The following statement is being issued by Levi & Korsinsky, LLP:
or otherwise acquired securities of CorMedix, Inc. ("CorMedix") (NYSE MKT: CRMD) .
that a securities class action lawsuit has been commenced in the USDC for the District of New Jersey. If you purchased or otherwise acquired CorMedix, Inc. securities between March 12, 2011 and June 29, 2015, . To get more information :
or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
The complaint alleges that, among other allegations, during the Class Period defendants' overstated the cost effectiveness and effectiveness of Neutrolin compared to currently established medical protocol, failed to disclose the use of paid stock promoters, and that insiders enriched themselves at the expense of shareholders by selling stock at inflated prices.
On June 29, 2015, an article by The Pump Stopper and featured on Seeking Alpha alleged that personnel involved in the formation of CorMedix had faced prior accusations of fraud, that Neutrolin's performance in clinical trials was vastly overstated, and that the Company had engaged stock promoters in order to inflate the Company's share price.
to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.07.2015 - 18:07 Uhr
Sprache: Deutsch
News-ID 407412
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 172 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD"
steht unter der journalistisch-redaktionellen Verantwortung von
Levi & Korsinsky, LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
